3T3-L1, NEFA release (basal)| Type of assay | Triglyceride hydrolysis | | Biological model | 3T3-L1 preadipocyte cell line (adipocyte-differentiated) | | Species | Mouse | | Endpoint | Non-esterified fatty acid release |
| 3T3L1-0001 | Lipolysis, Lipolysis | Triglyceride hydrolysis | 3T3-L1 preadipocyte cell line (adipocyte-differentiated) | Mouse | Non-esterified fatty acid release | Photometry | Basal | |
3T3-L1, lipid neosynthesis (basal)| Type of assay | Lipogenesis | | Biological model | 3T3-L1 preadipocyte cell line (adipocyte-differentiated) | | Species | Mouse | | Endpoint | Lipid neosynthesis |
| 3T3L1-0004 | Lipogenesis, fat storage, Lipogenesis, fat storage | Lipogenesis | 3T3-L1 preadipocyte cell line (adipocyte-differentiated) | Mouse | Lipid neosynthesis | [14C]-acetate incorporation | Basal | |
3T3-L1, lipid neosynthesis (basal)| Type of assay | Lipogenesis | | Biological model | 3T3-L1 preadipocyte cell line (adipocyte-differentiated) | | Species | Mouse | | Endpoint | Lipid neosynthesis |
| 3T3L1-0005 | Lipogenesis, fat storage, Lipogenesis, fat storage | Lipogenesis | 3T3-L1 preadipocyte cell line (adipocyte-differentiated) | Mouse | Lipid neosynthesis | [3H]-glucose incorporation | Basal | |
3T3-L1, lipid neosynthesis (basal)| Type of assay | Lipogenesis | | Biological model | 3T3-L1 preadipocyte cell line (adipocyte-differentiated) | | Species | Mouse | | Endpoint | Fatty acid uptake |
| 3T3L1-0006 | Lipogenesis, fat storage, Lipogenesis, fat storage | Lipogenesis | 3T3-L1 preadipocyte cell line (adipocyte-differentiated) | Mouse | Fatty acid uptake | [14C]-oleate incorporation | Basal | |
3T3-L1, active lipoprotein lipase (LPL) production (basal)| Type of assay | Lipogenesis | | Biological model | 3T3-L1 preadipocyte cell line (adipocyte-differentiated) | | Species | Mouse | | Endpoint | Synthesis / release of active LPL |
| 3T3L1-0008 | Lipogenesis, fat storage, Lipogenesis, fat storage | Lipogenesis | 3T3-L1 preadipocyte cell line (adipocyte-differentiated) | Mouse | Synthesis / release of active LPL | Radioactivity | Basal | |
3T3-L1, differentiation, lipid content/analysis| Type of assay | Morphological changes/lipid accumulation | | Biological model | 3T3-L1 preadipocyte cell line | | Species | Mouse | | Endpoint | Lipid labeling, Lipid labeling + Morphological changes |
| 3T3L1-0010 | Adipocyte differentiation, Adipocyte differentiation | Morphological changes/lipid accumulation | 3T3-L1 preadipocyte cell line | Mouse | Lipid labeling, Lipid labeling + Morphological changes | Fluorescence / imaging | Differentiation mix | |
Phosphodiesterase inhibition (purified enzyme)| Type of assay | Signal transduction | | Biological model | | | Species | Mouse | | Endpoint | Phosphodiesterase activity |
| BIOCH-0013 | Enzyme activity assays, Lipolysis, Lipolysis | Signal transduction | | Mouse | Phosphodiesterase activity | Radioactivity | Basal | |
Lipoprotein lipase (LPL) activity| Type of assay | Enzyme activity | | Biological model | | | Species | Bovine | | Endpoint | LPL activity |
| BIOCH-0016 | Enzyme activity assays, Lipogenesis, fat storage, Lipogenesis, fat storage | Enzyme activity | | Bovine | LPL activity | Radioactivity | Basal | |
Alpha-amylase inhibition| Type of assay | Enzyme activity | | Biological model | | | Species | Human | | Endpoint | alpha-amylase inhibition |
| BIOCH-0022 | Enzyme activity assays, Gastroenterology, lipid metabolism | Enzyme activity | | Human | alpha-amylase inhibition | Photometry | Basal | |
Pancreatic lipase activity| Type of assay | Enzyme activity | | Biological model | | | Species | Pig | | Endpoint | Pancreatic lipase activity |
| BIOCH-0026 | Enzyme activity assays, Lipogenesis, fat storage, Lipogenesis, fat storage | Enzyme activity | | Pig | Pancreatic lipase activity | Photometry | Basal | |
FABP4 Inhibitor/Ligand screening assay| Type of assay | Binding assay | | Biological model | | | Species | Human | | Endpoint | FABP4 |
| BIOCH-0030 | Lipogenesis, fat storage | Binding assay | | Human | FABP4 | Fluorescence | Basal | |
HMSC differentiation in adipocytes| Type of assay | Gene expression | | Biological model | Mesenchymal stem cells (hMSC) | | Species | Human | | Endpoint | Selection of genes of interest, qPCRarray (16 genes), qPCRarray (32 genes), qPCRarray (64 genes) |
| HMSC-0001 | Adipocyte differentiation, Adipocyte differentiation | Gene expression | Mesenchymal stem cells (hMSC) | Human | Selection of genes of interest, qPCRarray (16 genes), qPCRarray (32 genes), qPCRarray (64 genes) | RT-qPCR, qPCRarray (standard or customized) | Differentiation mix | |
Adipocytes, NEFA release (basal)| Type of assay | Triglyceride hydrolysis | | Biological model | Hypodermal adipocytes (ex vivo) | | Species | Human | | Endpoint | Non-esterified fatty acid release |
| NHA-0001 | Lipolysis, Lipolysis | Triglyceride hydrolysis | Hypodermal adipocytes (ex vivo) | Human | Non-esterified fatty acid release | Photometry | Basal | |
Adipocytes, glycerol release (basal)| Type of assay | Triglyceride hydrolysis | | Biological model | Hypodermal adipocytes (ex vivo) | | Species | Human | | Endpoint | Glycerol release |
| NHA-0002 | Lipolysis, Lipolysis | Triglyceride hydrolysis | Hypodermal adipocytes (ex vivo) | Human | Glycerol release | Fluorescence | Basal | |
NHA, cAMP content (basal)| Type of assay | Signal transduction | | Biological model | Hypodermal adipocytes (ex vivo) | | Species | Human | | Endpoint | cAMP content |
| NHA-0003 | Lipolysis, Lipolysis | Signal transduction | Hypodermal adipocytes (ex vivo) | Human | cAMP content | ELISA / EIA | Basal | |
Adipocytes, lipid neosynthesis (basal)| Type of assay | Lipogenesis | | Biological model | Hypodermal adipocytes (ex vivo) | | Species | Human | | Endpoint | Lipid neosynthesis |
| NHA-0004 | Lipogenesis, fat storage, Lipogenesis, fat storage | Lipogenesis | Hypodermal adipocytes (ex vivo) | Human | Lipid neosynthesis | [14C]-acetate incorporation | Basal | |
Preadipocytes, NEFA release (basal)| Type of assay | Triglyceride hydrolysis | | Biological model | Differentiated preadipocytes | | Species | Human | | Endpoint | Non-esterified fatty acid release |
| PREAD-0001 | Lipolysis, Lipolysis | Triglyceride hydrolysis | Differentiated preadipocytes | Human | Non-esterified fatty acid release | Photometry | Basal | |
Preadipocytes, glycerol release (basal)| Type of assay | Triglyceride hydrolysis | | Biological model | Differentiated preadipocytes | | Species | Human | | Endpoint | Glycerol release |
| PREAD-0002 | Lipolysis, Lipolysis | Triglyceride hydrolysis | Differentiated preadipocytes | Human | Glycerol release | Fluorescence | Basal | |
Preadipocytes, differentiation, lipid content| Type of assay | Morphological changes/lipid accumulation | | Biological model | Preadipocytes | | Species | Human | | Endpoint | Lipid labeling, Lipid labeling + Morphological changes |
| PREAD-0007 | Adipocyte differentiation, Adipocyte differentiation | Morphological changes/lipid accumulation | Preadipocytes | Human | Lipid labeling, Lipid labeling + Morphological changes | Fluorescence / imaging | Differentiation mix | |
Preadipocytes, adipogenic differentiation markers (differentiation mix stimulation)| Type of assay | Gene expression | | Biological model | Preadipocytes | | Species | Human | | Endpoint | mRNA: e.g. LPL, FABP4, PPARG, COL1A1..., qPCRarray (16 genes), qPCRarray (64 genes) |
| PREAD-0009 | Adipocyte differentiation, Adipocyte differentiation | Gene expression | Preadipocytes | Human | mRNA: e.g. LPL, FABP4, PPARG, COL1A1..., qPCRarray (16 genes), qPCRarray (64 genes) | RT-qPCR, qPCRarray (standard or customized) | Differentiation mix | |
